=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-08
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Core Scientific, Inc./tx (CORZ)
CIK: 0001839341
--- Reporting Owner ---
Name: DUCHENE TODD M
CIK: 0001248745
Role: Officer (See remarks)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-08 | Code: S (Open market sale)
Shares: -10,000 | Price: $18.67
Total Value: $186,735.00
Shares Owned After: 1,217,896 | Ownership: D (Direct)
Footnotes:
[F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
[F2] The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $19.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
[F3] Reflects the transfer of 700,000 shares that the Reporting Person held directly to a grantor retained annuity trust of which the Reporting Person is the sole trustee on September 10, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
--- Derivative Transactions ---
[Transaction #1]
Security: Tranche 1 Warrants
Date: 2026-09-09 | Code: G (Gift)
Shares: -95,000 | Price: $0.00
Exercise Price: $6.81
Exercisable: N/A | Expires: 2027-01-23
Shares Owned After: 422,133 | Ownership: D (Direct)
Footnotes:
[F5] Reflects a charitable donation.
[F6] Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
Footnotes:
[F3] Reflects the transfer of 700,000 shares that the Reporting Person held directly to a grantor retained annuity trust of which the Reporting Person is the sole trustee on September 10, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
[F4] Represents shares held by a grantor retained annuity trust of which the Reporting Person is the sole trustee.
--- Footnotes (Complete Index) ---
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $19.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: Reflects the transfer of 700,000 shares that the Reporting Person held directly to a grantor retained annuity trust of which the Reporting Person is the sole trustee on September 10, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
F4: Represents shares held by a grantor retained annuity trust of which the Reporting Person is the sole trustee.
F5: Reflects a charitable donation.
F6: Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
--- Signature ---
/s/ /s/ Todd DuChene (2026-09-10)
